Page last updated: 2024-09-02

1,2-dimyristoylphosphatidylethanolamine and epirubicin

1,2-dimyristoylphosphatidylethanolamine has been researched along with epirubicin in 1 studies

Compound Research Comparison

Studies
(1,2-dimyristoylphosphatidylethanolamine)
Trials
(1,2-dimyristoylphosphatidylethanolamine)
Recent Studies (post-2010)
(1,2-dimyristoylphosphatidylethanolamine)
Studies
(epirubicin)
Trials
(epirubicin)
Recent Studies (post-2010) (epirubicin)
2160595,4531,8381,570

Protein Interaction Comparison

ProteinTaxonomy1,2-dimyristoylphosphatidylethanolamine (IC50)epirubicin (IC50)
Genome polyprotein 0.75
Tyrosine-protein kinase FynHomo sapiens (human)5.181

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Aguilar, LF; Colina, JR; Contreras, D; Jemiola-Rzeminska, M; Petit, K; Strzalka, K; Suwalsky, M1

Other Studies

1 other study(ies) available for 1,2-dimyristoylphosphatidylethanolamine and epirubicin

ArticleYear
Toxic effects of the anticancer drug epirubicin in vitro assayed in human erythrocytes.
    Toxicology in vitro : an international journal published in association with BIBRA, 2020, Volume: 68

    Topics: Antibiotics, Antineoplastic; Calorimetry, Differential Scanning; Cells, Cultured; Dimyristoylphosphatidylcholine; Epirubicin; Erythrocytes; Humans; Liposomes; Microscopy, Electron, Scanning; Phosphatidylethanolamines; X-Ray Diffraction

2020